RAPT Therapeutics Stock (NASDAQ:RAPT), Quotes and News Summary

Q: What sector and industry does RAPT Therapeutics (RAPT) operate in?

RAPT Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

RAPT Therapeutics Stock (NASDAQ: RAPT) stock price, news, charts, stock research, profile.

Open	-
Close	-
Volume / Avg.	0 / 1.334M
Day Range	- - -
52 Wk Range	6.860 - 27.350
Market Cap	$278.398M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	11.51%
Days to Cover	3.71

Recent News

Rivian Automotive Reports Q4 Loss, Joins Etsy, Lucid Group And Other Big Stocks Moving Lower In Thursday's Pre-Market Session

U.S. stock futures were higher this morning, with the Nasdaq futures trading higher by around 2% on Thursday.

Avi Kapoor

What's Going On With RAPT Therapeutics Stock On Wednesday?

Latest developments in RAPT Therapeutics as FDA places clinical hold on Phase 2b trial for zelnecirnon in dermatitis and asthma. Stock rebounds and analyst downgrades.

Vandana Singh

Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-quarter financial results and reduced its expected quarterly dividend approximately 50% to 40 cents per share.

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trend

Nov 23

Feb

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About RAPT Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy RAPT Therapeutics (RAPT) stock?

You can purchase shares of RAPT Therapeutics (NASDAQ: RAPT) through any online brokerage.

View our list of the best stock brokerages.

Who are RAPT Therapeutics's (RAPT) competitors?

Other companies in RAPT Therapeutics’s space includes: Renovaro (NASDAQ:RENB), Inozyme Pharma (NASDAQ:INZY), Inovio Pharmaceuticals (NASDAQ:INO), Adaptimmune Therapeutics (NASDAQ:ADAP) and Tevogen Bio Holdings (NASDAQ:TVGN).

What is the target price for RAPT Therapeutics (RAPT) stock?

The latest price target for RAPT Therapeutics (NASDAQ: RAPT) was reported by HC Wainwright & Co. on Wednesday, April 10, 2024. The analyst firm set a price target for 0.00 expecting RAPT to fall to within 12 months (a possible -100.00% downside). 20 analyst firms have reported ratings in the last year.

Current Stock Price for RAPT Therapeutics (RAPT)?

The stock price for RAPT Therapeutics (NASDAQ: RAPT) is $8 last updated April 24, 2024 at 7:47 PM EDT.

Does RAPT Therapeutics (RAPT) pay a dividend?

There are no upcoming dividends for RAPT Therapeutics.

When is RAPT Therapeutics (NASDAQ:RAPT) reporting earnings?

RAPT Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.

Is RAPT Therapeutics (RAPT) going to split?

There is no upcoming split for RAPT Therapeutics.

What sector and industry does RAPT Therapeutics (RAPT) operate in?

RAPT Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-